Hussein K - Search Results

1

Circulating blasts or myeloid precursor cells in peripheral blood can predict success of cytogenetic analysis.

Wiktor AE, Hanson CA, Hodnefield JM, Hussein K, Tefferi A, Van Dyke DL. Wiktor AE, et al. Among authors: hussein k. Leuk Res. 2009 Jul;33(7):e75-6. doi: 10.1016/j.leukres.2008.11.022. Epub 2009 Jan 6. Leuk Res. 2009. PMID: 19128830 No abstract available.

2

Peripheral blood cytogenetic studies in myelofibrosis: overall yield and comparison with bone marrow cytogenetic studies.

Hussein K, Ketterling RP, Dewald GW, Van Dyke DL, Mesa R, Hanson CA, Tefferi A. Hussein K, et al. Leuk Res. 2008 Oct;32(10):1597-600. doi: 10.1016/j.leukres.2007.12.005. Epub 2008 Feb 1. Leuk Res. 2008. PMID: 18241918

3

Peripheral blood cytogenetic studies in hematological neoplasms: predictors of obtaining metaphases for analysis.

Hussein K, Ketterling RP, Hulshizer RL, Kuffel DG, Wiktor AE, Hanson CA, Tefferi A, Van Dyke DL. Hussein K, et al. Eur J Haematol. 2008 Apr;80(4):318-21. doi: 10.1111/j.1600-0609.2007.01021.x. Epub 2007 Dec 18. Eur J Haematol. 2008. PMID: 18088399

4

Lenalidomide-induced durable hematological and cytogenetic remission in del(5q)-associated de novo acute myeloid leukemia.

Hussein K, Tefferi A. Hussein K, et al. Leuk Res. 2009 Aug;33(8):e132-3. doi: 10.1016/j.leukres.2009.02.026. Epub 2009 Mar 21. Leuk Res. 2009. PMID: 19304324 No abstract available.

5

Conventional cytogenetics in myelofibrosis: literature review and discussion.

Hussein K, Van Dyke DL, Tefferi A. Hussein K, et al. Eur J Haematol. 2009 May;82(5):329-38. doi: 10.1111/j.1600-0609.2009.01224.x. Epub 2009 Jan 9. Eur J Haematol. 2009. PMID: 19141119 Review.

6

JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival.

Tefferi A, Lasho TL, Patnaik MM, Finke CM, Hussein K, Hogan WJ, Elliott MA, Litzow MR, Hanson CA, Pardanani A. Tefferi A, et al. Among authors: hussein k. Leukemia. 2010 Jan;24(1):105-9. doi: 10.1038/leu.2009.225. Epub 2009 Oct 22. Leukemia. 2010. PMID: 19847199

7

International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis.

Hussein K, Pardanani AD, Van Dyke DL, Hanson CA, Tefferi A. Hussein K, et al. Blood. 2010 Jan 21;115(3):496-9. doi: 10.1182/blood-2009-08-240135. Epub 2009 Nov 9. Blood. 2010. PMID: 19901264 Free article.

8

Cytogenetic correlates of TET2 mutations in 199 patients with myeloproliferative neoplasms.

Hussein K, Abdel-Wahab O, Lasho TL, Van Dyke DL, Levine RL, Hanson CA, Pardanani A, Tefferi A. Hussein K, et al. Am J Hematol. 2010 Jan;85(1):81-3. doi: 10.1002/ajh.21562. Am J Hematol. 2010. PMID: 19957346 Free PMC article.

9

Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.

Hussein K, Huang J, Lasho T, Pardanani A, Mesa RA, Williamson CM, Ketterling RP, Hanson CA, Van Dyke DL, Tefferi A. Hussein K, et al. Eur J Haematol. 2009 Apr;82(4):255-9. doi: 10.1111/j.1600-0609.2009.01216.x. Epub 2008 Feb 10. Eur J Haematol. 2009. PMID: 19215287

10

The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis.

Mesa RA, Schwager S, Radia D, Cheville A, Hussein K, Niblack J, Pardanani AD, Steensma DP, Litzow MR, Rivera CE, Camoriano J, Verstovsek S, Sloan J, Harrison C, Kantarjian H, Tefferi A. Mesa RA, et al. Among authors: hussein k. Leuk Res. 2009 Sep;33(9):1199-203. doi: 10.1016/j.leukres.2009.01.035. Epub 2009 Feb 27. Leuk Res. 2009. PMID: 19250674 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

492 results

Search Page